These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32474745)

  • 1. Utilization patterns and temporal trends of internal mammary nodal irradiation at a tertiary cancer center.
    Misra S; Lee G; Maganti M; Koch CA
    Breast Cancer Res Treat; 2020 Jul; 182(2):367-379. PubMed ID: 32474745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival outcomes following internal mammary node irradiation in stage II-III breast cancer: results of a large retrospective study with 12-year follow-up.
    Chang JS; Park W; Kim YB; Lee IJ; Keum KC; Lee CG; Choi DH; Suh CO; Huh SJ
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):867-72. PubMed ID: 23747215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trial.
    Zhao XR; Fang H; Tang Y; Hu ZH; Jing H; Liang L; Yan XN; Song YW; Jin J; Liu YP; Chen B; Tang Y; Qi SN; Li N; Lu NN; Men K; Hu C; Zhang YH; Li YX; Wang SL
    BMC Cancer; 2021 Nov; 21(1):1185. PubMed ID: 34742270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer: A Randomized Phase 3 Clinical Trial.
    Kim YB; Byun HK; Kim DY; Ahn SJ; Lee HS; Park W; Kim SS; Kim JH; Lee KC; Lee IJ; Kim WT; Shin HS; Kim K; Shin KH; Nam CM; Suh CO
    JAMA Oncol; 2022 Jan; 8(1):96-105. PubMed ID: 34695841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Internal mammary node irradiation improves 8-year survival in breast cancer patients: results from a retrospective cohort study in real-world setting.
    Wang X; Luo J; Jin K; Chen X; Zhang L; Meng J; Zhang X; Zhang Z; Shao Z; Bazan JG; Guo X; Yang Z; Yu X
    Breast Cancer; 2020 Mar; 27(2):252-260. PubMed ID: 31696449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does internal mammary node irradiation affect treatment outcome in clinical stage II-III breast cancer patients receiving neoadjuv ant chemotherapy?
    Kim KH; Noh JM; Kim YB; Chang JS; Keum KC; Huh SJ; Choi DH; Park W; Suh CO
    Breast Cancer Res Treat; 2015 Aug; 152(3):589-99. PubMed ID: 26202053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer.
    Thorsen LB; Offersen BV; Danø H; Berg M; Jensen I; Pedersen AN; Zimmermann SJ; Brodersen HJ; Overgaard M; Overgaard J
    J Clin Oncol; 2016 Feb; 34(4):314-20. PubMed ID: 26598752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internal mammary node irradiation in node-positive breast cancer treated with mastectomy and taxane-based chemotherapy.
    Cho WK; Chang JS; Park SG; Kim N; Choi DH; Kim H; Kim YB; Park W; Suh CO
    Breast; 2021 Oct; 59():37-43. PubMed ID: 34126377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer.
    Qi WX; Cao L; Zheng S; Xu C; Cai R; Xu H; Cai G; Chen J
    BMC Cancer; 2022 Dec; 22(1):1356. PubMed ID: 36575421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative).
    Ollila DW; Cirrincione CT; Berry DA; Carey LA; Sikov WM; Hudis CA; Winer EP; Golshan M
    J Am Coll Surg; 2017 Apr; 224(4):688-694. PubMed ID: 28089784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends and Patterns of Utilization of Hypofractionated Postmastectomy Radiotherapy: A National Cancer Database Analysis.
    Venigalla S; Guttmann DM; Jain V; Sharma S; Freedman GM; Shabason JE
    Clin Breast Cancer; 2018 Oct; 18(5):e899-e908. PubMed ID: 29550285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nodal Response to Neoadjuvant Chemotherapy Predicts Receipt of Radiation Therapy After Breast Cancer Diagnosis.
    Fayanju OM; Ren Y; Suneja G; Thomas SM; Greenup RA; Plichta JK; Rosenberger LH; Force J; Hyslop T; Hwang ES
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):377-389. PubMed ID: 31678225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Trends in Multimodality Therapy for Locally Advanced Gastric Cancer.
    Sada YH; Smaglo BG; Tran Cao HS; Mok H; Musher BL; Massarweh NN
    J Surg Res; 2019 May; 237():41-49. PubMed ID: 30694790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Regional Nodal Irradiation for Breast Cancer Patients with Supraclavicular and/or Internal Mammary Lymph Node Involvement: A Multicenter, Retrospective Study (KROG 16-14).
    Kim K; Jeong Y; Shin KH; Kim JH; Ahn SD; Kim SS; Suh CO; Kim YB; Choi DH; Park W; Cha J; Chun M; Lee DS; Lee SY; Kim JH; Park HJ; Jung W
    Cancer Res Treat; 2019 Oct; 51(4):1500-1508. PubMed ID: 30913866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of internal mammary lymph node biopsy on the therapeutic decision and survival of patients with breast cancer.
    Ozmen V; Ozcinar B; Bozdogan A; Eralp Y; Yavuz E; Dincer M
    Eur J Surg Oncol; 2015 Oct; 41(10):1368-72. PubMed ID: 26210653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer.
    Halverson KJ; Taylor ME; Perez CA; Garcia DM; Myerson R; Philpott G; Levy J; Simpson JR; Tucker G; Rush C
    Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):593-9. PubMed ID: 8330987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are there changes in characteristics and therapy of young patients with early-onset breast cancer in Germany over the last decade?
    Banz-Jansen C; Heinrichs A; Hedderich M; Waldmann A; Wedel B; Mebes I; Diedrich K; Rody A; Fischer D
    Arch Gynecol Obstet; 2013 Aug; 288(2):379-83. PubMed ID: 23407999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.